1. Home
  2. VEEE vs VIRX Comparison

VEEE vs VIRX Comparison

Compare VEEE & VIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VEEE
  • VIRX
  • Stock Information
  • Founded
  • VEEE 1994
  • VIRX 2007
  • Country
  • VEEE United States
  • VIRX United States
  • Employees
  • VEEE N/A
  • VIRX N/A
  • Industry
  • VEEE Marine Transportation
  • VIRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VEEE Industrials
  • VIRX Health Care
  • Exchange
  • VEEE Nasdaq
  • VIRX Nasdaq
  • Market Cap
  • VEEE 6.1M
  • VIRX 6.8M
  • IPO Year
  • VEEE 2021
  • VIRX N/A
  • Fundamental
  • Price
  • VEEE $0.41
  • VIRX $0.08
  • Analyst Decision
  • VEEE
  • VIRX Buy
  • Analyst Count
  • VEEE 0
  • VIRX 4
  • Target Price
  • VEEE N/A
  • VIRX $5.00
  • AVG Volume (30 Days)
  • VEEE 1.1M
  • VIRX 2.1M
  • Earning Date
  • VEEE 03-25-2025
  • VIRX 03-06-2025
  • Dividend Yield
  • VEEE N/A
  • VIRX N/A
  • EPS Growth
  • VEEE N/A
  • VIRX N/A
  • EPS
  • VEEE N/A
  • VIRX N/A
  • Revenue
  • VEEE $20,949,492.00
  • VIRX N/A
  • Revenue This Year
  • VEEE $76.99
  • VIRX N/A
  • Revenue Next Year
  • VEEE N/A
  • VIRX N/A
  • P/E Ratio
  • VEEE N/A
  • VIRX N/A
  • Revenue Growth
  • VEEE N/A
  • VIRX N/A
  • 52 Week Low
  • VEEE $0.31
  • VIRX $0.07
  • 52 Week High
  • VEEE $1.37
  • VIRX $1.31
  • Technical
  • Relative Strength Index (RSI)
  • VEEE 47.54
  • VIRX 26.18
  • Support Level
  • VEEE $0.40
  • VIRX $0.14
  • Resistance Level
  • VEEE $0.45
  • VIRX $0.19
  • Average True Range (ATR)
  • VEEE 0.06
  • VIRX 0.02
  • MACD
  • VEEE -0.00
  • VIRX -0.01
  • Stochastic Oscillator
  • VEEE 21.80
  • VIRX 0.00

About VEEE Twin Vee PowerCats Co.

Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.

About VIRX Viracta Therapeutics Inc.

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.

Share on Social Networks: